These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5522091)

  • 1. [Experiences with cytostatic agents in multiple sclerosis].
    Danielczyk W
    Wien Klin Wochenschr; 1970 Oct; 82(40):697-9. PubMed ID: 5522091
    [No Abstract]   [Full Text] [Related]  

  • 2. [Etiopathogenic problems in multiple sclerosis. Etiology, pathogenesis and therapeutic concept].
    Meyer-Rienecker H; Hitzschke B
    Nervenarzt; 1974 Mar; 45(3):133-41. PubMed ID: 4598802
    [No Abstract]   [Full Text] [Related]  

  • 3. [Electrophoresis of cerebrospinal fluid in multiple sclerosis depending on the clinical form, duration of the disease and the treatment].
    Mikulska E
    Ann Acad Med Stetin; 1971; 17():371-96. PubMed ID: 5149567
    [No Abstract]   [Full Text] [Related]  

  • 4. [Guidelines for drug treatment of multiple sclerosis].
    Kollegger H; Vass K; Marschall I; Koch G; Deecke L
    Wien Klin Wochenschr; 1993; 105(16):443-52. PubMed ID: 7692677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunosuppressive agents in multiple sclerosis. Preliminary trials with Proresid].
    Danielczyk W
    Wien Med Wochenschr; 1968 Nov; 118(44):934-7. PubMed ID: 5710171
    [No Abstract]   [Full Text] [Related]  

  • 6. Complications from intrathecal steroid therapy in patients wsith multiple sclerosis.
    Nelson DA; Vates TS; Thomas RB
    Acta Neurol Scand; 1973; 49(2):176-88. PubMed ID: 4740461
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of ulcerative colitis with cytostatic agents].
    Chlund K
    Wien Med Wochenschr; 1970 Apr; 120(16):274. PubMed ID: 5527127
    [No Abstract]   [Full Text] [Related]  

  • 8. The limitations of immunosuppressant therapy in Multiple Sclerosis.
    Sedal L
    J Clin Neurosci; 2000 Nov; 7(6):563-4; discussion 564-5. PubMed ID: 11029245
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mitoxantrone, a new reality].
    Ruiz-Peña JL; Izquierdo G
    Rev Neurol; 2003 Apr 1-15; 36(7):698-9. PubMed ID: 12666055
    [No Abstract]   [Full Text] [Related]  

  • 10. Natalizumab: immune effects and implications for therapy.
    Hauser SL; Weiner HL
    Ann Neurol; 2006 May; 59(5):731-2. PubMed ID: 16634007
    [No Abstract]   [Full Text] [Related]  

  • 11. [Globoid cell leukodystrophy].
    Grippo J; Menkes JH
    Acta Neurol Latinoam; 1970; 16(1):74-87. PubMed ID: 5538059
    [No Abstract]   [Full Text] [Related]  

  • 12. The management of multiple sclerosis. II. Serial neurologic examinations and use of corticotropin and glucocorticoids.
    McFarland HR
    Mo Med; 1969 Feb; 66(2):113-6. PubMed ID: 4302927
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunosuppressive treatment of progressive chronic polyarthritis. Experiences with an antimitotic drug from the podophyllin series (Proresid)].
    Chlud K; Prohaska E; Zeitlhofer J; Pfaller C; Friza B
    Munch Med Wochenschr; 1968 Jan; 110(2):88-97. PubMed ID: 5695131
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mitoxantrone].
    Pericot I; Montalban X
    Neurologia; 2003; 18(6):318-23. PubMed ID: 12838451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoxantrone in multiple sclerosis.
    Neuhaus O; Kieseier BC; Hartung HP
    Adv Neurol; 2006; 98():293-302. PubMed ID: 16400840
    [No Abstract]   [Full Text] [Related]  

  • 16. [The significance of C-reactive protein determination in the diagnosis and evaluation of the clinical course of multiple sclerosis].
    Hrazdira CL; Zouhar A; Polcáková M
    Cesk Neurol Neurochir; 1980 Sep; 43(5):290-5. PubMed ID: 7418055
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cytostatic chemotherapy in the treatment of malignant tumors].
    Langhammer H; Klemm J; Pabst HW
    Arztl Forsch; 1966 Aug; 20(8):393-403. PubMed ID: 6014703
    [No Abstract]   [Full Text] [Related]  

  • 18. Cushingoid picture with Proresid.
    Könyves AL; Almqvist EG; Holmberg DH
    Br J Rheumatol; 1994 Dec; 33(12):1198. PubMed ID: 8000762
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of experimental arthritis with the cytostatic agent podophyllinic acid ethylhydrazide].
    Szántó L; Lörincz G; Gömör B
    Arzneimittelforschung; 1968 Jul; 18(7):886-9. PubMed ID: 5756046
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of mitoxantrone cardiotoxicity in multiple sclerosis patients by dexrazoxane.
    Bernitsas E; Wei W; Mikol DD
    Ann Neurol; 2006 Jan; 59(1):206-9. PubMed ID: 16374818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.